Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Ldl Binding'

Ldl Binding published presentations and documents on DocSlides.

Abnormalities of LDL metabolism
Abnormalities of LDL metabolism
by briana-ranney
Physiology, pathophysiology and treatments. Under...
Is lower better? LDL targets and beyond.
Is lower better? LDL targets and beyond.
by trish-goza
Implications of the relationship between risk fac...
Looking to FOURIER: What do the trials tell us about LDL lowering and cardiovascular events?
Looking to FOURIER: What do the trials tell us about LDL lowering and cardiovascular events?
by min-jolicoeur
NICE –CG 181 Continuum of CVD Risk and its trea...
Is lower better? LDL targets and beyond.
Is lower better? LDL targets and beyond.
by olivia-moreira
Implications of the relationship between risk fac...
LDL Apheresis in Drug Resistant Nephrotic Syndrome
LDL Apheresis in Drug Resistant Nephrotic Syndrome
by obrien
Rodney D Gilbert. Patient JM. 14 year old girl, pr...
LDL is causal of atherosclerosis
LDL is causal of atherosclerosis
by morgan
Evidence from . meta-analyses of . Mendelian. . r...
LDL-CHOLESTEROL Presented By
LDL-CHOLESTEROL Presented By
by williams
Assist.Lecturer. Aseel. . Ghassan. . Daoud. M.Sc...
PCSK9 Inhibition: LDL Lowering
PCSK9 Inhibition: LDL Lowering
by SweetiePie
PCSK9 inhibitors. New option for dyslipidemia. Ali...
Lifestyle Tips to Lower Your LDL Cholesterol
Lifestyle Tips to Lower Your LDL Cholesterol
by dandy
Advice f rom the National Lipid Association Clini...
Residual risk: Is LDL target enough?
Residual risk: Is LDL target enough?
by candy
An interpretation of the continuous relationship b...
New Insights in
New Insights in
by yoshiko-marsland
the Understanding . of . Cholesterol Metabolism:....
Cholesterol and C.V.D.
Cholesterol and C.V.D.
by sherrill-nordquist
Learning outcome. Most cholesterol is synthesised...
Genetic Variants of Proprotein Convertase Subtilisin/Kexin
Genetic Variants of Proprotein Convertase Subtilisin/Kexin
by mitsue-stanley
Type 9 (PCSK9). Implications for Low-Density Lipo...
DIABETES AND LIPID
DIABETES AND LIPID
by yoshiko-marsland
S-KHALILZADEH. Lipids are hydrophobic molecules t...
The State of
The State of
by olivia-moreira
Dyslipidemia. . Treatment. USA-145-101385. © . ...
Health Guide
Health Guide
by min-jolicoeur
By: Rebekah O’Bryan, Naomi Belcher, and Miranda...
Novel therapies for the prevention of atherosclerotic vascu
Novel therapies for the prevention of atherosclerotic vascu
by debby-jeon
Prof. . John . Kastelein. Academic Medical Centre...
Advancing the Understanding
Advancing the Understanding
by briana-ranney
of Cholesterol Metabolism:. The Role of . Proprot...
Familial
Familial
by sherrill-nordquist
Hypercholesterolaemia. . N. ew local pathways. D...
Familial Hypercholesterolemia
Familial Hypercholesterolemia
by faustina-dinatale
KEY POINTS . FH is an autosomal dominant genetic...
Plant stanol ester in the treatment and prevention guidelin
Plant stanol ester in the treatment and prevention guidelin
by stefany-barnette
0. International Atherosclerosis Society, 2013. A...
Protecting the heart and the kidney:
Protecting the heart and the kidney:
by marina-yarberry
Implications from the SHARP trial. Dr. Christina ...
0 Circulation and Gas Exchange
0 Circulation and Gas Exchange
by tatyana-admore
The fluid that moves around in the circulatory sy...
Hypertension & Cholesterol
Hypertension & Cholesterol
by cheryl-pisano
Blake Wachter, MD, PhD. Idaho Heart Institute. Ep...
KA 7d
KA 7d
by olivia-moreira
: Learning Outcomes. State where cholesterol is s...
Familial Hypercholesterolemia
Familial Hypercholesterolemia
by pasty-toler
Developed by . Ms. . Shawna . Morrison, Dr. Judit...
Lipid Metabolism
Lipid Metabolism
by kittie-lecroy
Chapter 29, . Stryer. Short Course. Lipid anabol...
Understanding Blood Lipids
Understanding Blood Lipids
by myesha-ticknor
and Their Relationship to Health. Mark Pettus MD...
Cholesterol Treatment Trialists’ (CTT) Collaboration
Cholesterol Treatment Trialists’ (CTT) Collaboration
by briana-ranney
Slide deck. CTT Collaboration: Background*. Histo...
협심증 ( 狹心症 )
협심증 ( 狹心症 )
by lois-ondreau
Kyung Woo Park, MD, PhD, MBA . Seoul National Uni...
Triglycerides and Risk for Atherothrombosis
Triglycerides and Risk for Atherothrombosis
by briana-ranney
Thomas Dayspring, MD, FACP. Clinical Assistant Pr...
FOURIER F urther cardiovascular
FOURIER F urther cardiovascular
by trish-goza
OU. tcomes. . R. esearch with PCSK9 . I. nhibiti...
Risk factors in heart disease
Risk factors in heart disease
by faustina-dinatale
Optimizing . patient care. William Cromwell, MD, ...
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
by pamella-moone
Hyperlipidemic. Subjects: A 52 Week Phase 3 Dou...
HOT TOPICS IN CHOLESTEROL
HOT TOPICS IN CHOLESTEROL
by tatyana-admore
Are Statins as Effective in Women as in Men? Upda...
American Association of Clinical Endocrinologists and American College of Endocrinology
American Association of Clinical Endocrinologists and American College of Endocrinology
by natalia-silvester
Guidelines for Management of Dyslipidemia . and P...
Update: Lipid Guidelines
Update: Lipid Guidelines
by yoshiko-marsland
DO NOT BURN THE COOKIES. Amy R. Woods, M.D.. a. ...
Cholesterol-Lowering Drugs
Cholesterol-Lowering Drugs
by cheryl-pisano
Victor Nadler. Objectives. By the end of this cla...
The Importance of Potential
The Importance of Potential
by pamella-moone
Statin. in High Risk Patient. Masrul Syafri. Bag...
Management of Common Comorbidities in Diabetes
Management of Common Comorbidities in Diabetes
by celsa-spraggs
1. Obesity. Management of Common Comorbidities in...